Investment Q&A

Q: I hold UNH in my US RRSP and RESP portfolios. With the recent decline and being in battleground with the democrates Medicare bill is it worth holding in these portfolios or is there a better US health care option out there? Considering there will be a lot of election noise later in the year.

Q: What is your opinion of this company? I feel like with social trends moving in the direction of "pets are more a part of the family" that people are willing to do what they can for their fur babies. Also with the trend of more meat and other live stock increasing in the diets around the world do you see this company as a good long term hold with the stock price increasing?
Thanks

Q: I saw your comments on GUD and they make sense. But if I told you I owned a stock that has been down 25 percent for 2 years and that it continually disappoints shareholders, (GUD took in only about 11 million in REVENUE last year, despite a market cap of 1.1 billion and 750 million cash sitting on the balance sheet. This is mind boggling, really) I think your answer would be that it's dead money and that I should move on. So while this might end up being a good long term investment for 'my grandchildren', it really doesn't seem to fit with your overall philosophy, does it?

Q: Please comment on the earnings results.

Q: I have been looking at CVS in the last few days as a long term hold, the dividend is quite attractive. The share price has dropped to what looks like a 5 year low, the Forward PE is at 8.6. How would you evaluate the long term prospects of CVS? Could the large merger it has gone through make future dividend increases doubtful?

Q: Do you know why UNH has been taking a hit in the last couple of days? I have not been able to find any information that would explain this. Thanks.

Q: Comments on the latest conjecture this morning?

Q: Hi team,
I have been holding PLI for quite a while and I was down 50% as of a few days ago. They've been surging in the last couple of days and now I'm only down 38%. Is this the time to get rid of it or do you think there's a reason to hold on. Is there any news as to why they are moving up?
Thanks

Q: Why the down day the earnings sounded good what are your thoughts?

Q: Good morning,
It appears you have no concerns about the quarter and the stock is taking a 10% hit today. Assuming the growth story is still intact. Would today be a good day to add to our existing holding? We are 30% down on this stock and our weighting has now fallen to slightly below 1%? Is now a good buying opportunity?
Thanks,
Kerri

Q: May i get your thoughts on the acquisition by Vitalhub of The Oak Group. May i also get your view on Vitalhub in general as it is beginning grow nicely over the past year. Thanks for your input.

Q: Hi Team
What do you think of DHR going forward with the addition of Bio Pharma. Have they taken up too much debt? Would be adding to ABBV, BDX and MDT in my rrsp. Thank-you in advance. Sam

Q: Hi, I received shares in this company (HLS) via a reverse takeover of ADM (Automodular) back in late '17.
I don't see any other questions on this company thus the inquiry. What is your valued opinion of HLS?
From their web page...'HLS Therapeutics is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products in the North American markets. We focus on products targeting the central nervous system and cardiovascular therapeutic areas. '
They seem to have a couple of drugs Vascepa, Clozaril and Absorica that are or will generate decent revenues going forward.
They also introduced a quarterly dividend recently and I know you favour companies when this occurs.
Are they a 'show me' story right now and patience is required for a couple quarters to see how they proceed, ie it looks like they will be filing for approval with Health Canada in early 2019 for Vascepa (it's already FDA approved).
Analysts targets are for around $20 for 2019 (from your 'Companies' page).

Cheers,
Steve

Q: Hi

I currently own GILD. Should I sell it and switch to BIIB or any other biotech. What are your thoughts about medical distribution companies (ABC, CAH, MCK) Which one would you recommend and any threat from Amazon. Should healthcare plans companies be part of healthcare portfolio and which one do you recommend.

Great service
Thanks
Ninad

Q: With SIS having 5 earning misses, I have lost confidence in this stock. Which stock would you recommend to replace it in the same sector?

Q: current thoughts on VMD as a long term hold. Also, is this a good entry point?

Q: Hi 5i team,
Canadian financials account for 24% of our portfolio and 2% of this is in MFC in my TFSA account. I've held it for a number of years and I am up 50%. Presently, our total holdings are 60% Canada; 30% US and 10% International. I am thinking of selling MFC and replacing it with a US ETF or a fairly safe growth stock. I only have 1% in healthcare (split evenly between VHT and UNH in TFSA account) and am considering topping up based on MFC sale. Would appreciate your thoughts on this move. Thanks.

Q: if you hold SIS at a 3%weight but are in a loss position in a rrsp would you sell to a 2% weight or just wait for earning to be released?
Thanks

Q: I am looking for a replacement for JNJ, recently sold. US$ to be held in a taxable account. Current healthcare holdings are Savaria, Knight, and Stryker.
2-3 suggestions would be appreciated.
Thank you

Q: Hi, Recent pre release took many of us by surprise. We are reviewing our portfolio position in Savaria (Currently 3.75%). For a Balanced Growth and Income portfolio, you have indicated in a recent response, the right weighting as 2-2.5%. But, 5i Balanced portfolio has 4.24 % weight presently (reduced from 4.5 to 5% earlier due to price decline).
Is your response based on the recent pre announcment of their results ? Are you recommending that we reduce our holding to recommneded weight, all else being same as Balanced Portfolio ? If so, when do you plan to make the change?
Thanks